Discover 2,226 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Francisco offers opportunities for individuals interested in taking part in paid studies as healthy volunteers, as well as those looking for studies for a specific medical condition. The city has a strong emphasis on cutting-edge research for conditions such as HIV/AIDS, oncology, kidney disease, PCOS, and endometriosis, among others. By participating, you can gain access to the latest healthcare innovations and contribute to pioneering medical progress.
Filter
2
Filter results
Results: 2,226
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Get alerts for new trials in your area by subscribing now
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for
Non-Small Cell Lung Cancer, NSCLC,
Location: San Francisco CA, Stanford CA, Sacramento CA, Duarte CA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06162221
Phase1, Phase2, Recruiting
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
for
Heart Failure With Reduced Ejection Fraction
Location: Walnut Creek CA, Salt Lake City UT, Aurora CO,
Sponsor: University of Colorado, Denver
Sex: All
Age: 18+
Code: NCT06526988
Recruiting
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
for
Recurrent Childhood Acute Myeloid Leukemia,
Location: San Francisco CA, Orange CA, Aurora CO, Minneapolis MN,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 18
Code: NCT06247787
Phase1, Recruiting
Validation of myStrength's Macropersonalization Engine
for
Depression, Anxiety, Trauma
Location: Menlo Park CA
Sponsor: Teladoc Health
Sex: All
Age: 18 - 70+
Code: NCT05417178
Recruiting
Study of ALTO-300 in MDD
for
Major Depressive Disorder
Location: Lafayette CA, Mather CA, Glendale CA, Los Angeles CA,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70
Code: NCT05922878
Phase2, Recruiting
Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®
for
Small Intestinal Bacterial Overgrowth
Location: Mountain View CA
Sponsor: Envivo Bio Inc
Sex: All
Age: 18 - 70+
Code: NCT06298409
Phase1, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Palo Alto CA, Burbank CA, La Jolla CA, Portland OR,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase3, Recruiting
Probiotic Administration for Adolescent Depression
for
Depression
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 15 - 24
Code: NCT06898788
Early_phase1, Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: San Francisco CA, Redding CA, Bakersfield CA,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
Location: San Francisco CA, Columbus OH, Gainesville FL,
Sponsor: Duke University
Sex: All
Age: 2 - 17
Code: NCT06654882
Phase3, Recruiting
Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab
for
Fanconi Anemia
Location: Stanford CA
Sponsor: Porteus, Matthew, MD
Sex: All
Age: 2+
Code: NCT04784052
Phase1, Phase2, Recruiting
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Palo Alto CA, Los Angeles CA, San Bernardino CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT05714085
Phase2, Phase3, Recruiting
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)